These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 983808)

  • 21. Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure.
    Finks SW; Finks AL; Self TH
    South Med J; 2006 Jan; 99(1):18-22. PubMed ID: 16466117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs that induce systemic lupus erythematosus inhibit complement component C4.
    Sim E; Gill EW; Sim RB
    Lancet; 1984 Aug; 2(8400):422-4. PubMed ID: 6147500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydralazine-induced lupus erythematosus-like syndrome.
    Irias JJ
    Am J Dis Child; 1975 Jul; 129(7):862-4. PubMed ID: 50009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of hydralazine and its main metabolites in slow and fast acetylators.
    Reece PA; Cozamanis I; Zacest R
    Clin Pharmacol Ther; 1980 Dec; 28(6):769-78. PubMed ID: 7438692
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetylation status using hydralazine in African hypertensives at Kenyatta National Hospital.
    Rashid JR; Kofi-Tsepko ; Juma FD
    East Afr Med J; 1992 Jul; 69(7):406-8. PubMed ID: 1396201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lupus syndrome induced by hydralazine: a common complication with low dose treatment.
    Cameron HA; Ramsay LE
    Br Med J (Clin Res Ed); 1984 Aug; 289(6442):410-2. PubMed ID: 6432120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced systemic lupus erythematosus.
    Weinstein A
    Prog Clin Immunol; 1980; 4():1-21. PubMed ID: 6992215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary infiltrations during dihydralazine treatment in a slow isoniazid-inactivator.
    Ripe E; Nilsson BS
    Scand J Respir Dis; 1972; 53(1):56-63. PubMed ID: 5052347
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydralazine-induced lupus: is there a toxic metabolic pathway?
    Timbrell JA; Facchini V; Harland SJ; Mansilla-Tinoco R
    Eur J Clin Pharmacol; 1984; 27(5):555-9. PubMed ID: 6519160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
    Reidenberg MM
    Arthritis Rheum; 1981 Aug; 24(8):1004-9. PubMed ID: 6169347
    [No Abstract]   [Full Text] [Related]  

  • 32. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA; Farid YY; Samad TA; Shihab SA
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac tamponade, associated with hydralazine therapy, in a patient with rapid acetylator status.
    Anandadas JA; Simpson P
    Br J Clin Pract; 1986 Jul; 40(7):305-6. PubMed ID: 3741750
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydralazine-induced relapsing polychondritis-like syndrome. Report of a case with severe chronic laryngeal complications.
    Dahlqvist A; Lundberg E; Ostberg Y
    Acta Otolaryngol; 1983; 96(3-4):355-9. PubMed ID: 6605652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medicaments as iatrogenic factors in the onset of lupoid syndromes].
    Galea G; Geavlete A
    Med Interna (Bucur); 1974 Jan; 26(1):89-94. PubMed ID: 4821155
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of association between slow acetylator status and spontaneous lupus erythematosus.
    Kumana CR; Chan MM; Wong KL; Wong RW; Kou M; Lauder IJ
    Clin Pharmacol Ther; 1990 Aug; 48(2):208-13. PubMed ID: 2379389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological side-effects of antihypertensive drugs.
    Holm G
    Acta Med Scand Suppl; 1979; 628():85-8. PubMed ID: 288303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acetylator phenotype of patients with systemic lupus erythematosus.
    Reidenberg MM; Martin JH
    Drug Metab Dispos; 1974; 2(1):71-3. PubMed ID: 4150137
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA
    N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.